New study aims to overcome barriers to HIV prevention in drug users
NCT ID NCT07385183
First seen Feb 03, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This study explores how to help people who use drugs begin and continue taking PrEP, a daily pill that prevents HIV. Researchers will follow 200 participants who test HIV-negative in the emergency department, offering them PrEP and tracking adherence over a year. The goal is not to test the medicine itself, but to understand real-world challenges like stigma and access, and find ways to improve HIV prevention for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREP ADHERENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.